Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jul 1;40(19):2176-2177.
doi: 10.1200/JCO.22.00497. Epub 2022 Apr 21.

Reply to L. Marandino et al

Martin R Stockler  1 , Andrew J Martin  1 , Haryana M Dhillon  1 , Ian D Davis  1 , Christopher J Sweeney  1
Affiliations
Comment

Reply to L. Marandino et al

Martin R Stockler et al. J Clin Oncol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Martin R. StocklerResearch Funding: Astellas Pharma (Inst), Bayer (Inst), Bionomics (Inst), Medivation (Inst), Pfizer (Inst), AstraZeneca (Inst), Bristol Myers Squibb (Inst), Roche (Inst), Amgen (Inst), Merck Sharp & Dohme (Inst), Tilray (Inst), BeiGene (Inst), Novartis (Inst)Travel, Accommodations, Expenses: Medivation/Pfizer Haryana M. DhillonHonoraria: BMS (Inst)Consulting or Advisory Role: Janssen Oncology (Inst) Ian D. DavisResearch Funding: Astellas Pharma (Inst), Pfizer (Inst), Roche/Genentech (Inst), MSD Oncology (Inst), AstraZeneca (Inst), Janssen Oncology (Inst), Eisai (Inst), Bayer (Inst), Amgen (Inst), Bristol Myers Squibb (Inst), Movember Foundation (Inst), Exelixis (Inst), Ipsen (Inst), Medivation (Inst), Seattle Genetics (Inst)Patents, Royalties, Other Intellectual Property: International Patent Application No: PCT/US2004/032147 (NY-ESO-1) through Ludwig Institute for Cancer Research Christopher J. SweeneyStock and Other Ownership Interests: LeuchemixConsulting or Advisory Role: Sanofi, Janssen Biotech, Astellas Pharma, Bayer, Genentech/Roche, AstraZeneca, Pfizer, Amgen, LillyResearch Funding: Janssen Biotech (Inst), Astellas Pharma (Inst), Sanofi (Inst), Bayer (Inst), Dendreon, Pfizer (Inst)Patents, Royalties, Other Intellectual Property: Leuchemix: parthenolide, dimethylaminoparthenolide. Exelixis: abiraterone plus cabozantinib combinationNo other potential conflicts of interest were reported.

Comment on

LinkOut - more resources